Inventor · Redwood City, CA, US

Andreas BUCKL

14Patents
4h-index
27Co-inventors
52Inventor score

Filing activity: Dec 20, 2018 → Jul 10, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US10590090B2 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors Chemistry; Metallurgy 12 Active
US11690915B2 Ras inhibitors Chemistry; Metallurgy 7 Active
US11566007B2 Ras inhibitors Human Necessities 7 Active
US11739074B2 Ras inhibitors Chemistry; Metallurgy 7 Active
US11168102B1 Bicyclic heteroaryl compounds and uses thereof Chemistry; Metallurgy 4 Active
US12202845B2 Ras inhibitors Chemistry; Metallurgy 2 Active
US11739093B2 Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitors Chemistry; Metallurgy 0 Active
US11673896B2 Pyridine compounds as allosteric SHP2 inhibitors Chemistry; Metallurgy 0 Active
US11634435B2 Polycyclic compounds as allosteric SHP2 inhibitors General 0 Revoked
US12365688B2 Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitors Chemistry; Metallurgy 0 Active
US12258366B2 Bicyclic heteroaryl compounds and uses thereof Chemistry; Metallurgy 0 Active
US11673901B2 Polycyclic compounds as allosteric SHP2 inhibitors Chemistry; Metallurgy 0 Active
US11702411B2 Pyridine, pyrazine, and triazine compounds as allosteric SHP2 inhibitors Chemistry; Metallurgy 0 Active
US11661401B2 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.